DARVIAS Injection 135mg

Darinaparsin, an organoarsenic compound with anticancer activity, is a mitochondrial-targeted agent being developed for the treatment of various hematologic and solid tumors. Darvias (darinaparsin) was approved by the PMDA in Japan in June 2022.

Facts about darinaparsin injection

Disease Indications-Lymphoma
Manufacturer-Solasia Pharma K.K.
Usage-Intravenous
Medicine Approved By-Pharmaceuticals and Medical Devices Agency (PMDA) ( no image)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “darinaparsin injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.